Tag: Vaxil Bio

March 1, 2018

Vaxil Granted First U.S. Patent for Its Cancer Immunotherapy Antibody Platform

VAXIL BIO (TSXV: VXL), an innovative Israeli cancer research company focused on immunotherapy, is pleased to announce that it has successfully...
January 31, 2018

Vaxil Completes Oversubscribed Financing to Advance Its Cancer Immunotherapy Research and Development

VAXIL BIO (TSXV: VXL), an innovative Israeli cancer immunotherapy company, is pleased to announce the closing of an oversubscribed equity financing...
April 13, 2017

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...